Welcome to our dedicated page for DANAHER /DE/ SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DANAHER /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DANAHER /DE/'s regulatory disclosures and financial reporting.
Danaher Corporation (DHR) reported an insider equity transaction by Executive Vice President Gregory M. Milosevich on a Form 4. On 11/15/2025, Milosevich disposed of 35 shares of Danaher common stock at a price of $221.21 per share in a transaction coded "F," which typically reflects shares withheld to cover taxes on equity awards. Following this small transaction, he directly beneficially owns 4,420 shares of Danaher common stock. No derivative securities transactions were reported.
Danaher Corporation (DHR) reported an insider equity transaction by its Executive Vice President, Julie A. Sawyer Montgomery. On 11/15/2025, she disposed of 265 shares of Danaher common stock at a price of $221.21 per share, reported under transaction code F. Following this transaction, she beneficially owns 16,653 shares of Danaher common stock directly.
Danaher (DHR) reported a Form 144 notice covering a planned sale of 3,298 shares of its common stock by Teri L. List through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $746,997. The shares relate to a stock option originally granted on 07/15/2016 and acquired and paid for in cash on 11/18/2025. As additional context, 706,349,563 common shares were outstanding, and during the prior three months List sold 2,778 common shares for gross proceeds of $586,319.96.
Danaher (DHR) reported an insider transaction by its EVP & Chief Financial Officer, Matthew McGrew. On 11/11/2025, he exercised 16,172 employee stock options at an exercise price of $62.85 per share and sold 16,172 common shares at a weighted average price of $214.6198.
Following these transactions, McGrew beneficially owns 20,062 common shares directly and 10,221.856 shares indirectly via a 401(k). The sale price reflected multiple trades between $214.580 and $214.810.
Danaher (DHR) insider transaction: Senior Vice President and General Counsel Brian W. Ellis reported option exercises and same‑day sales on 11/12/2025. He exercised employee stock options at $58.59 and sold the resulting shares in open market transactions at weighted average prices disclosed in footnotes.
Ellis exercised 7,109 options at $58.59, then sold 7,109 shares at $219.2131. He also exercised 14,667 options at $58.59, then sold 14,667 shares at $219.2321. Following these transactions, he beneficially owned 14,553 shares directly.
Footnotes state the sale prices were weighted averages within disclosed ranges, and describe the vesting schedules of the original option grants.
Danaher (DHR) director and officer Mitchell P. Rales reported open‑market sales totaling 437,000 shares of common stock on November 12, 2025 at weighted average prices of $217.64, $218.27, $219.43 and $220.15.
Following these transactions, he beneficially owns 553,228 shares directly. Indirect holdings include 912,654 shares through the Mitchell P. Rales Family Trust, 667 by a 401(k) plan, 3,256 in a trust for a daughter (plus another 3,256 in a second trust), and 25,671,000 shares through single‑member LLCs.
Danaher (DHR) disclosed insider activity by its SVP, Human Resources. On 11/10/2025, the officer exercised employee stock options for 4,176 shares at $88.24 (transaction code M), then sold 4,176 shares at a weighted average price of $210.4436 and 998 shares at $210.3118 (transaction code S).
The weighted average sale price reflects multiple trades between $210.4101 and $210.570. After these transactions, the officer beneficially owned 2,625 shares directly.
Danaher (DHR): A stockholder filed a Form 144 notice to sell up to 437,000 shares of common stock, with an aggregate market value of $91,743,780. The filing lists Monness, Crespi, Hardt & Co., Inc. as broker, an approximate sale date of 11/12/2025, and the NYSE as the exchange.
The seller previously acquired 1,900,000 shares on 06/11/2021 via a distribution from Capital Yield Corporation tied to a closely held corporation liquidation. In the past three months, Mitchell P. Rales reported a sale of 600,000 shares on 10/31/2025 for gross proceeds of $129,635,820. Shares outstanding were 706,349,563.
Danaher (DHR): A selling securityholder filed a Form 144 notice to sell up to 21,776 shares of Danaher common stock. The filing lists an aggregate market value of $4,773,863.62, with an approximate sale date of 11/12/2025. The planned sales are through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via an option granted on 02/24/2016, with payment listed as cash on 11/12/2025. This notice reflects an intention to sell under Rule 144 and does not itself complete a transaction.
A Form 144 notice discloses a proposed sale of 16,172 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $3,470,831.41. The planned sale is listed for the NYSE on or about 11/11/2025.
The seller acquired the shares via an option granted on 11/15/2015 and paid cash on 11/11/2025. Shares outstanding were 706,349,563.